Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aprea Therapeutics Inc (APRE)
NASDAQ:APRE
RESEARCH TOOLSreports
Holding APRE?
Track your performance easily
Aprea Therapeutics (APRE) Ownership Overview
12.36% Insiders
2.84% Mutual Funds
31.34% Other Institutional Investors
3.30% ETFs
50.15% Public Companies and
Individual Investors
The ownership structure of Aprea Therapeutics (APRE) stock is a mix of institutional, retail, and individual investors. Approximately 37.48% of the company’s stock is owned by Institutional Investors, 12.36% is owned by Insiders, and 50.15% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 25, 2024 | Marc Duey Director | xxxxxxxxxxxxx | $29531 |
| Oct 24, 2024 | Oren Gilad President & Ceo,director | xxxxxxxxxxxxx | $1955 |
| Oct 17, 2024 | Marc Duey Director | xxxxxxxxxxxxx | $131700 |
| Oct 16, 2024 | Marc Duey Director | xxxxxxxxxxxxx | $490 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 335,195 | Insider | 6.17% | 965,362 | |
| 234,253 | Insider | 4.31% | 674,649 | |
| 173,842 | Institution | 3.20% | 500,665 | |
| 114,842 | Institution | 2.11% | 330,745 | |
| 44,730 | Insider | 0.82% | 128,822 | |
| 34,282 | Institution | 0.63% | 98,732 | |
| 19,368 | Insider | 0.36% | 55,780 | |
| 18,509 | Insider | 0.34% | 53,306 | |
| 9,184 | Insider | 0.17% | 26,450 | |
| 6,730 | Insider | 0.12% | 19,382 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 114,842 | Institution | 2.11% | 330,745 | |
| 34,282 | Institution | 0.63% | 98,732 | |
| 4,441 | Institution | 0.08% | 12,790 | |
| 996 | Institution | 0.02% | 2,868 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 145,280 | Institution | 2.67% | 568,045 | |
| 28,562 | Institution | 0.53% | 111,677 | |
| 5,083 | Institution | 0.09% | 14,690 | |
| 409 | Institution | <0.01% | 1,182 |
FAQ
Who Owns Aprea Therapeutics Inc (APRE)?
According to the latest TipRanks data, approximately 31.34% of the company's stock is held by institutional investors, 12.36% is held by insiders, and 50.15% is held by retail investors.
What percentage of Aprea Therapeutics Inc (APRE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 31.34% of Aprea Therapeutics Inc (APRE) stock is held by institutional investors.
What percentage of Aprea Therapeutics Inc (APRE) stock is held by retail investors?
According to the latest TipRanks data, approximately 50.15% of Aprea Therapeutics Inc (APRE) stock is held by retail investors.
Who owns the most shares of Aprea Therapeutics Inc (APRE)?
Oren Gilad owns the most shares of Aprea Therapeutics Inc (APRE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.